Journal article
Differential response to neoadjuvant endocrine therapy for Black/African American and White women in NCDB
Breast cancer research and treatment, Vol.203(1), pp.125-134
01/2024
DOI: 10.1007/s10549-023-07106-8
PMCID: PMC10771585
PMID: 37740855
Abstract
Purpose Compared to White women, there are higher mortality rates in Black/African American (BAA) women with hormone receptor-positive breast cancer (HR + BC) which may be partially due to differences in treatment resistance. We assessed factors associated with response to neoadjuvant endocrine therapy (NET). Methods The National Cancer Database (NCDB) was queried for women with clinical stage I–III HR + BC diagnosed 2006–2017 and treated with NET. Univariate and multivariate analyses described associations between the sample, duration of NET, and subsequent treatment response, defined by changes between clinical and pathological staging. Results The analytic sample included 9864 White and 1090 BAA women. Compared to White women, BAA women were younger, had more co-morbidities, were higher stage at presentation, and more likely to have > 24 weeks of NET. After excluding those with unknown pT/N/M, 3521 White and 365 BAA women were evaluated for NET response. On multivariate analyses, controlling for age, stage, histology, HR positivity, and duration of NET, BAA women were more likely to downstage to pT0/Tis (OR 3.0, CI 1.2–7.1) and upstage to Stage IV (OR 2.4, CI 1.002–5.6). None of the women downstaged to pT0/Tis presented with clinical stage III disease; only 2 of the women upstaged to Stage IV disease presented with clinical Stage I disease. Conclusion Independent of NET duration and clinical stage at presentation, BAA women were more likely to experience both complete tumor response and progression to metastatic disease. These results suggest significant heterogeneity in tumor biology and warrant a more nuanced therapeutic approach to HR + BC.
Details
- Title: Subtitle
- Differential response to neoadjuvant endocrine therapy for Black/African American and White women in NCDB
- Creators
- Veronica Jones - City Of Hope National Medical CenterMary C. Schroeder - University of IowaMya L. RobersonJames De Andrade - University of IowaIngrid M. Lizarraga - University of Iowa
- Resource Type
- Journal article
- Publication Details
- Breast cancer research and treatment, Vol.203(1), pp.125-134
- DOI
- 10.1007/s10549-023-07106-8
- PMID
- 37740855
- PMCID
- PMC10771585
- NLM abbreviation
- Breast Cancer Res Treat
- ISSN
- 0167-6806
- eISSN
- 1573-7217
- Grant note
- DOI: 10.13039/100008307, name: Beckman Research Institute, City of Hope, award: 5K12CA001727; DOI: 10.13039/100017804, name: City of Hope
- Language
- English
- Electronic publication date
- 09/23/2023
- Date published
- 01/2024
- Academic Unit
- Surgery; Pharmacy Practice and Science
- Record Identifier
- 9984472658102771
Metrics
11 Record Views